Norman Sussman is Chief Medical Officer at DURECT CORP (DRRX). They have made 1 open-market trade across 1 company since 2021, most recently 2025-09-11.
CIK 0001358508
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DRRX | 46,425 | $89K |
Shares reported on the most recent Form 4, priced at the 2025-07-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DRRX | SELL | 2021-12-10 | 2024-09-11 | $1.06 | $10K | -18.1% | -16.1% | -48.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.